cyc 202 has been researched along with Bright Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, A; Bhangal, G; Cook, T; McClue, S; Pusey, CD; Sheryanna, AM; Smith, J; Tam, FW | 1 |
| Griffin, SV; Krofft, RD; Pippin, JW; Shankland, SJ | 1 |
| Barnett, A; Eitner, F; Floege, J; Kerjaschki, D; Kunter, U; Milovanceva-Popovska, M; Ostendorf, T; Petermann, A; Rong, S | 1 |
| Fischer, PM; Gianella-Borradori, A | 1 |
| Benigni, A; Casiraghi, F; Cavinato, RA; Conti, S; Corna, D; Remuzzi, G; Rottoli, D; Zoja, C | 1 |
1 review(s) available for cyc 202 and Bright Disease
| Article | Year |
|---|---|
Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Clinical Trials as Topic; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; Flavonoids; Glomerulonephritis; Hematologic Neoplasms; HIV Infections; Humans; Molecular Sequence Data; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Transcription, Genetic | 2005 |
4 other study(ies) available for cyc 202 and Bright Disease
| Article | Year |
|---|---|
Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
Topics: Administration, Oral; Animals; Cell Proliferation; Creatinine; Cyclin-Dependent Kinases; Disease Models, Animal; Glomerulonephritis; Kidney Glomerulus; Macrophages; Male; Protein Kinase Inhibitors; Proteinuria; Purines; Rats; Rats, Inbred WKY; Roscovitine; Severity of Illness Index; Time Factors | 2011 |
Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis.
Topics: Animals; CDC2-CDC28 Kinases; Cell Proliferation; Cyclin-Dependent Kinase 2; DNA; Epithelial Cells; Extracellular Matrix Proteins; Glomerulonephritis; Kidney; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Purines; Roscovitine | 2005 |
R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury.
Topics: Animals; Cell Division; Cyclin-Dependent Kinases; Disease Models, Animal; Enzyme Inhibitors; Glomerulonephritis; Kidney; Kidney Glomerulus; Male; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Urothelium | 2005 |
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
Topics: Animals; Anti-Inflammatory Agents; Autoimmunity; B-Lymphocytes; Cell Proliferation; Cyclin-Dependent Kinases; Disease Models, Animal; Drug Therapy, Combination; Female; Glomerulonephritis; Longevity; Lupus Erythematosus, Systemic; Methylprednisolone; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Protein Kinase Inhibitors; Proteinuria; Purines; Roscovitine; T-Lymphocytes | 2007 |